Personality Disorders and Eating Disorders

Log in for full access to this session if you are registered.

Registration Options

Registrant Resources

Sorry, but you are not an authorized user. Please register for the course at the top of this page.

Faculty Information

Kelly N. Gable, PharmD, BCPP

Learning Objectives

  1. Describe the clinical presentation, signs and symptoms, DSM-IV-TR criteria, and pathophysiology for personality and eating disorders.
  2. Explain the use of common rating scales for research, diagnosis and management of personality and eating disorders.
  3. Discuss the efficacy of pharmacologic and nonpharmacologic treatment options in the acute and long-term management of personality and eating disorders.
  4. Outline the mechanisms of action, pharmacokinetic and pharmacodynamic, pharmacogenetic properties, adverse events, drug interactions, and warnings/precautions for medications used to treat personality and eating disorders.
  5. Describe treatment guidelines and clinical trials, including study design, strengths and weaknesses, and significance of findings for borderline personality disorder, anorexia nervosa, bulimia nervosa, and binge eating disorder.
  6. Select an evidenced-based drug therapy regimen (drug, dose, schedule and duration of therapy) for stabilizing symptoms and preventing relapse given the clinical presentation of a specific patient.
  7. Outline a plan for monitoring the safety and efficacy of drug therapy, including laboratory tests and managing adverse effects for medications used to treat personality and eating disorders.
  8. Discuss the role of drug therapy in the management of personality and eating disorders in special populations (e.g., pregnancy/lactation, children, and elderly).
  9. Identify essential information to discuss during patient counseling about treatment for personality and eating disorders.

Course Requirements

Login or register to help identify topics from this page.